Integra LifeSciences Holdings Profit Margin 2006-2018 | IART
Current and historical gross margin, operating margin and net profit margin for Integra LifeSciences Holdings (IART) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Integra LifeSciences Holdings net profit margin as of December 31, 2018 is 4.13%.
|Integra LifeSciences Holdings Annual Profit Margins
|Integra LifeSciences Holdings Quarterly Profit Margins
||Medical Instruments Manufacturing
Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic surgery, neurosurgery, reconstructive and general surgery. Integra's orthopedic products include devices and implants for foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. Integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. Integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. Surgeons don't have a minute to waste. They navigate a world of uncertainty while making thousands of decisions every day. These decisions directly affect patients - and surgeons.